STOCKSERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NECUpdated 2026-05-03
Here’s whether Surgery Partners, Inc. Common Stock (SGRY) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bearish.
🔴
Bearish
Positives: above the 50-day MA (medium-term momentum positive). Concerns: trading below the 200-day MA (long-term downtrend); 50-day MA is falling (-0.54% over 10 days); weak 1-year return of -36.4%. Currently 41.0% off its 52-week high. Score: -3/7.
SGRY is trading below its 200-day MA ($17.67) — a key warning sign the longer-term trend is under pressure. An RSI of 67.9 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of -36.4% compares to +27.9% for SPY (trailed the market by 64.3%). The current 41.0% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.
$10,000 invested 1 year ago→ $6,362 today
vs. S&P 500 (SPY) — same period trailed market by 64.3%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✗Above 200-day MA ($17.67)
✓Above 50-day MA ($13.43)
✓RSI(14) neutral zone (30–70) — currently 67.9
✗Positive return (-36.4%)
!Within 10% of period high (−41.0%)
Period Range $14.27
$11.41$24.18
RSI (14) 67.9
0 · OversoldOverbought · 100
Key Metrics
Price$14.27
Period Return-36.4%
Period High$24.18
Period Low$11.41
Drawdown−41.0%
MA-50$13.43
MA-200$17.67
RSI (14)67.9
Avg Volume (30d)1.1M
vs. SPYtrailed by 65.4%
Return Rank#1002 of 1236
Trend Signals
Price is below the 200-day moving average ($17.67)